Candriam Equities L Biotechnology Class R-H Fonds
210,04
CHF
+5,24
CHF
+2,56
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 6,34% |
| Amgen Inc | US0311621009 | 5,32% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,09% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,87% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,37% |
| BioNTech SE ADR | US09075V1026 | 3,59% |
| argenx SE | NL0010832176 | 2,72% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,57% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,50% |
| Insmed Inc | US4576693075 | 2,28% |
| Sonstige | 60,34% |